Stocktoria
INTUITIVE SURGICAL INC ISRG
Nasdaq · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2000-06-13 · LEI
INTUITIVE SURGICAL INC financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.1B | $8.4B | $7.1B | $6.2B | $5.7B | $4.4B | $4.5B | $3.7B | $3.1B | $2.7B |
| Gross profit | $6.6B | $5.6B | $4.7B | $4.2B | $4.0B | $2.9B | $3.1B | $2.6B | $2.2B | $1.9B |
| R&D expense | $1.3B | $1.1B | $998.8M | $879.0M | $671.0M | $595.1M | $557.3M | $418.1M | $328.6M | $239.6M |
| SG&A expense | $2.4B | $2.1B | $2.0B | $1.7B | $1.5B | $1.2B | $1.2B | $986.6M | $810.5M | $703.6M |
| Operating income | $2.9B | $2.3B | $1.8B | $1.6B | $1.8B | $1.0B | $1.4B | $1.2B | $1.1B | $949.7M |
| Income tax | $434.8M | $336.3M | $141.6M | $262.4M | $162.2M | $140.2M | $120.4M | $154.5M | $433.9M | $247.0M |
| Net income | $2.9B | $2.3B | $1.8B | $1.3B | $1.7B | $1.1B | $1.4B | $1.1B | $670.9M | $738.3M |
| EPS (diluted) | $7.87 | $6.42 | $5.03 | $3.65 | $4.66 | $2.94 | $3.85 | $3.16 | $1.92 | $2.09 |
| Operating cash flow | $3.0B | $2.4B | $1.8B | $1.5B | $2.1B | $1.5B | $1.6B | $1.2B | $1.1B | $1.1B |
| Cash & equivalents | $3.4B | $2.0B | $2.8B | $1.6B | $1.3B | $1.6B | $1.2B | $857.9M | $648.2M | $1.0B |
| Inventory | $1.8B | $1.5B | $1.2B | $893.2M | $587.1M | $601.5M | $595.5M | $409.0M | $241.2M | $182.3M |
| Total assets | $20.5B | $18.7B | $15.4B | $13.0B | $13.6B | $11.2B | $9.7B | $7.8B | $5.8B | $6.5B |
| Total liabilities | $2.5B | $2.2B | $2.0B | $1.9B | $1.6B | $1.4B | $1.4B | $1.2B | $996.4M | $709.1M |
| Shareholders' equity | $17.9B | $16.5B | $13.4B | $11.1B | $12.0B | $9.8B | $8.3B | $6.7B | $4.8B | $5.8B |
Growth · year-over-year · Revenue CAGR 15.7%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +20.5% | +17.2% | +14.5% | +9.0% | +31.0% | -2.7% | +20.3% | +18.7% | +16.0% | +13.5% |
| Net income growth | +23.0% | +29.2% | +36.0% | -22.4% | +60.7% | -23.1% | +22.3% | +68.1% | -9.1% | +25.4% |
| EPS growth | +22.6% | +27.6% | +37.8% | -21.7% | +58.5% | -23.6% | +21.7% | +64.5% | -7.8% | +20.8% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.